JP2015520628A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520628A5
JP2015520628A5 JP2015509510A JP2015509510A JP2015520628A5 JP 2015520628 A5 JP2015520628 A5 JP 2015520628A5 JP 2015509510 A JP2015509510 A JP 2015509510A JP 2015509510 A JP2015509510 A JP 2015509510A JP 2015520628 A5 JP2015520628 A5 JP 2015520628A5
Authority
JP
Japan
Prior art keywords
drug delivery
delivery system
implant
lacrimal implant
lacrimal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015509510A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015520628A (ja
JP6213560B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/000694 external-priority patent/WO2013164671A1/en
Publication of JP2015520628A publication Critical patent/JP2015520628A/ja
Publication of JP2015520628A5 publication Critical patent/JP2015520628A5/ja
Application granted granted Critical
Publication of JP6213560B2 publication Critical patent/JP6213560B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015509510A 2012-05-03 2013-02-27 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法 Active JP6213560B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US61/642,287 2012-05-03
US201261644401P 2012-05-08 2012-05-08
US201261644397P 2012-05-08 2012-05-08
US61/644,397 2012-05-08
US61/644,401 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US61/659,921 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US61/680,641 2012-08-07
US201261717615P 2012-10-23 2012-10-23
US61/717,615 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (en) 2012-05-03 2013-02-27 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

Publications (3)

Publication Number Publication Date
JP2015520628A JP2015520628A (ja) 2015-07-23
JP2015520628A5 true JP2015520628A5 (enExample) 2016-04-14
JP6213560B2 JP6213560B2 (ja) 2017-10-18

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015509510A Active JP6213560B2 (ja) 2012-05-03 2013-02-27 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法

Country Status (7)

Country Link
EP (1) EP2844224B1 (enExample)
JP (1) JP6213560B2 (enExample)
CN (1) CN105473130A (enExample)
CA (1) CA2872338C (enExample)
HK (1) HK1222810A1 (enExample)
IN (1) IN2014DN09713A (enExample)
WO (1) WO2013164671A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021107A2 (en) 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma
US12544258B2 (en) 2023-01-30 2026-02-10 Jeffrey Whitsett Aqueous micro shunt

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
DE69311361T2 (de) 1992-10-13 1998-01-08 Alcon Lab Inc Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
US20040170685A1 (en) 2003-02-26 2004-09-02 Medivas, Llc Bioactive stents and methods for use thereof
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
ES2767136T3 (es) 2004-01-05 2020-06-16 Nicox Sa Derivados de prostaglandinas
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
EP1765454B1 (en) 2004-07-02 2016-04-13 Mati Therapeutics Inc. Treatment medium delivery device for the eye
EP2004172B1 (en) 2006-03-31 2019-03-13 Mati Therapeutics Inc. Drug delivery structures and compositions for nasolacrimal system
US20100114309A1 (en) * 2006-12-26 2010-05-06 De Juan Jr Eugene Drug delivery implants for inhibition of optical defects
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
ES2732555T3 (es) 2007-09-07 2019-11-25 Mati Therapeutics Inc Implantes lagrimales y métodos relacionados
US9011361B2 (en) 2007-09-07 2015-04-21 Mati Therapeutics Inc. Lacrimal implant detection
MX2010002618A (es) 2007-09-07 2010-11-10 Qlt Plug Delivery Inc Herramientas de insercion y extraccion para implantes lagrimales.
EP2207529B1 (en) 2007-09-07 2014-12-31 Mati Therapeutics Inc. Drug cores for sustained release of therapeutic agents
MX2010012022A (es) * 2008-05-09 2011-03-15 Qlt Plug Delivery Inc Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular.
CA2750381C (en) * 2009-01-23 2021-03-16 Qlt Inc. Sustained released delivery of one or more agents
WO2010096822A2 (en) * 2009-02-23 2010-08-26 Qlt Plug Delivery, Inc. Lacrimal implants and related methods
US20120245539A1 (en) 2009-11-27 2012-09-27 Qlt Inc. Lacrimal implants including split and insertable drug core

Similar Documents

Publication Publication Date Title
ES2727203T3 (es) Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
CN102014816B (zh) 泪管植入物及相关方法
JP5415262B2 (ja) 活性剤送達用の涙点プラグ
JP6385423B2 (ja) 治療物質送達用の眼移植片
ES2740352T3 (es) Dispositivo ocular
TW200950817A (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US20090306608A1 (en) Ophthalmic devices for the controlled release of active agents
JP2003515528A (ja) ドラッグデリバリ製剤
JP2009508587A (ja) 眼の処置を提供するための薬剤送達装置および方法
SI2799064T1 (en) Biodegradable eye implant
AU2012204106A1 (en) Method for delivering ophthalmic drugs
TW201201782A (en) Punctal plugs for controlled release of therapeutic agents
AU2005282894A1 (en) Counter pressure device for ophthalmic drug delivery
AU2005269599A1 (en) Implantable device having reservoir with controlled release of medication and method of manufacturing the same
WO2016031535A1 (ja) 眼瞼内装用具
CN102781452B (zh) 减少与皮质类固醇的眼内使用相关的眼压的发生率的方法
US20220331160A1 (en) Static pin insertion tool for lacrimal implant
JP2015520628A (ja) 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法
Campochiaro Pharmacokinetics of sustained-delivery fluocinolone acetonide for DMO
Yong-rong et al. The clinical analysis of posterior capsule rapture during phacoemulsification